⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMRX News
Amneal Pharmaceuticals, Inc. Class A Common Stock
Airway Therapeutics Appoints Biopharma Leader Joe Todisco to Board of Directors USA - English USA - Français USA - español USA - English
prnewswire.com
CRMD
AMRX
PRGS
Airway Therapeutics nomme Joe Todisco, leader du secteur biopharmaceutique, à son conseil d'administration USA - Français USA - español USA - English
prnewswire.com
CRMD
AMRX
RNG
PRGS
Airway Therapeutics Appoints Biopharma Leader Joe Todisco to Board of Directors USA - English USA - español USA - Français
prnewswire.com
CRMD
AMRX
Airway Therapeutics beruft den führenden Biopharma-Experten Joe Todisco in den Vorstand USA - Deutsch USA - español USA - Français USA - English
prnewswire.com
CRMD
AMRX
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
globenewswire.com
AMRX
Amneal to Report First Quarter 2026 Results on May 1, 2026
globenewswire.com
AMRX
Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month
globenewswire.com
AMRX
Doxorubicin Market Outlook 2026-2030 & 2035: Predicted to Surge to $2 Billion by 2030, Bolstered by Expanding Access to Cancer Care
globenewswire.com
PFE
JNJ
BAX
AMRX
American Parkinson Disease Association Kicks Off Awareness Month with Launch of New Public Service Announcement
prnewswire.com
AMRX
Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry
globenewswire.com
PFE
NVS
EXEL
BMY
AMRX
JNJ